Zebrafish in Drug Discovery
Seiten
2019
Royal Society of Chemistry (Verlag)
978-1-78262-434-9 (ISBN)
Royal Society of Chemistry (Verlag)
978-1-78262-434-9 (ISBN)
- Titel wird leider nicht erscheinen
- Artikel merken
This book covers the latest technologies and tools important for zebrafish-based drug discovery and toxicity research.
USP: Introducing state-of-the-art zebrafish technologies to a general drug discovery audience
Special chapter: Summary of intellectual property situation for zebrafish technologies relevant for drug discovery
Cross promotion with the Issues in Toxicology Series books
Societies, professional bodies or companies interested in hearing about this book:
Drug discovery societies and organizations
therapeutic area societies and organizations
developmental biology societies and organizations
rare disease organizations and patient groups
pharmaceutical companies, CROs
USPTO, EPO
Suitable journals (not abbreviations) to which a review copy of your book can be sent:
Nature
Science
Nature Reviews Drug Discovery
Trends in Drug Discovery
Zebrafish
ACS Chemical Biology
Nature Chemical Biology
others (to be determined)
Forthcoming conferences/exhibitions at which we can display the book or publicity material:
- 2015 European Meeting on Zebrafish Development and Genetics, Oslo, Norway
- 2016 Meeting on Zebrafish Development and Genetics, Madison, Wisconsin
general drug discovery meetings (BIO, ICDDT, BioEurope, ...)
indication area-specific meetings (SfN, AES, ...)
biodiscovery meetings (GA, ASP, ...)
Websites that may be approached to publicise the book:
www.zfin.org
drug discovery societies and organizations
therapeutic area societies and organizations
developmental biology societies and organizations
national and international scientific societies and funding organizations (NIH, NSF, DFG, BMBF, MPG, Wellcome, Lilly, ...)
rare disease organizations and patient groups
national research organizations (Helmholz, Leibniz, Fraunhofer, ...)
USP: Introducing state-of-the-art zebrafish technologies to a general drug discovery audience
Special chapter: Summary of intellectual property situation for zebrafish technologies relevant for drug discovery
Cross promotion with the Issues in Toxicology Series books
Societies, professional bodies or companies interested in hearing about this book:
Drug discovery societies and organizations
therapeutic area societies and organizations
developmental biology societies and organizations
rare disease organizations and patient groups
pharmaceutical companies, CROs
USPTO, EPO
Suitable journals (not abbreviations) to which a review copy of your book can be sent:
Nature
Science
Nature Reviews Drug Discovery
Trends in Drug Discovery
Zebrafish
ACS Chemical Biology
Nature Chemical Biology
others (to be determined)
Forthcoming conferences/exhibitions at which we can display the book or publicity material:
- 2015 European Meeting on Zebrafish Development and Genetics, Oslo, Norway
- 2016 Meeting on Zebrafish Development and Genetics, Madison, Wisconsin
general drug discovery meetings (BIO, ICDDT, BioEurope, ...)
indication area-specific meetings (SfN, AES, ...)
biodiscovery meetings (GA, ASP, ...)
Websites that may be approached to publicise the book:
www.zfin.org
drug discovery societies and organizations
therapeutic area societies and organizations
developmental biology societies and organizations
national and international scientific societies and funding organizations (NIH, NSF, DFG, BMBF, MPG, Wellcome, Lilly, ...)
rare disease organizations and patient groups
national research organizations (Helmholz, Leibniz, Fraunhofer, ...)
Introduction; chapters on tools e.g. genetic tools and imaging; chapters on disease models as bioassays for drug screening e.g. for cardiovascular diseases and inflammation; intellectual property; aquaculture
| Erscheint lt. Verlag | 2.7.2019 |
|---|---|
| Reihe/Serie | Drug Discovery |
| Zusatzinfo | No |
| Verlagsort | Cambridge |
| Sprache | englisch |
| Maße | 156 x 234 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Studium ► 2. Studienabschnitt (Klinik) ► Pharmakologie / Toxikologie | |
| Naturwissenschaften ► Biologie ► Biochemie | |
| ISBN-10 | 1-78262-434-1 / 1782624341 |
| ISBN-13 | 978-1-78262-434-9 / 9781782624349 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Hardcover (2024)
Thomas Karow (Verlag)
CHF 79,95
Buch | Hardcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 138,60
